H.R. 5582 · 115th Congress
Abuse Deterrent Access Act of 2018
Key: what the circles and colors mean
Each circle is a bill. The ring fills as it moves through Congress:
Under the number: the Yea · Nay count of its final (or latest) recorded vote. On a member's page, the small badge is how that member voted: Y Yea / Aye, N Nay / No, P Present, – Not voting.
Gold and violet are only for Yea and Nay; they never mean a party. A member's party is the letter on their photo.
Passed the House without a recorded vote, then expired. It passed by voice vote or unanimous consent, which don't record how each member voted, but didn't become law before the 115th Congress ended.
R
CarterSponsor6 cosponsors · 2 D, 4 R
2 signed on when it was introduced; the rest joined later. Cosponsors who withdrew aren't shown.
- House Introduced Apr 23, 2018
- House Passed Jun 12, 2018
What it does: CRS summary · Passed House amended · Jun 12, 2018
Abuse Deterrent Access Act of 2018
(Sec. 2) This bill requires the Centers for Medicare & Medicaid Services to report to Congress on the adequacy of access to abuse-deterrent opioid formulations for individuals with chronic pain enrolled in a prescription drug plan under Medicare or Medicare Advantage (MA). The report must account for any barriers preventing enrollees from accessing such formulations under Medicare or MA.
Written by the nonpartisan Congressional Research Service. All summary versions on Congress.gov
About this bill and sources
Official title: Abuse Deterrent Access Act of 2018
Latest action (Jun 13, 2018): Received in the Senate and Read twice and referred to the Committee on Finance.
Policy area: Health · Origin: House · Introduced: Apr 23, 2018
Official page on Congress.gov · Bill text (GovInfo) · Status record (XML)
- House Introduced Apr 23, 2018
- House Passed Jun 12, 2018
No recorded floor vote found.